Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Intermediate-risk Prostate Cancer”

Showing 20 of 0 results

Not applicableLooking for participantsNCT02865330
What this trial is testing

Spanish Urological Association Registry of Patients on Active Surveillance

Who this might be right for
Prostate Cancer
Fundación Instituto Valenciano de Oncología 946
Testing effectiveness (Phase 2)Study completedNCT00006365
What this trial is testing

External-Beam Radiation Therapy Plus Implanted Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 138
Testing effectiveness (Phase 2)Study completedNCT02028988
What this trial is testing

Enzalutamide + External Beam Rt For Prostate

Who this might be right for
Intermediate Risk Prostate Cancer
Dana-Farber Cancer Institute 64
Large-scale testing (Phase 3)Active Not RecruitingNCT01584258
What this trial is testing

Prostate Advances in Comparative Evidence

Who this might be right for
Prostate Cancer
Royal Marsden NHS Foundation Trust 2,205
Testing effectiveness (Phase 2)Study completedNCT02770391
What this trial is testing

Apalutamide and Leuprolide in Intermediate and High-risk Prostate Cancer

Who this might be right for
Prostate Cancer
Case Comprehensive Cancer Center 54
Not applicableUnknownNCT04100811
What this trial is testing

Identification of Clinically Insignificant or Significant Prostate Cancer With the miR Scientific Sentinel™ Platform

Who this might be right for
Prostate Cancer
miR Scientific LLC 2,019
Testing effectiveness (Phase 2)Looking for participantsNCT07644598
What this trial is testing

MRI-based Focal Intraprostatic Simultaneous Integrated Boost (SIB) Intensification With De-escalated Adaptive-risk SBRT for Patients With Low to Intermediate Risk Prostate Cancer

Who this might be right for
Prostate CancerLocalized Prostate Carcinoma
Georgetown University 58
Not applicableUnknownNCT05584787
What this trial is testing

Transperineal Laser Ablation for Low- and Intermediate Risk Prostate Cancer: a Single Cohort Analysis

Who this might be right for
Prostate Cancer
San Carlo di Nancy Hospital 20
Not applicableActive Not RecruitingNCT05345444
What this trial is testing

Radiation Therapy and IRreversible Electroporation for Intermediate Risk Prostate Cancer (RTIRE)

Who this might be right for
Prostate Cancer
Weill Medical College of Cornell University 48
Testing effectiveness (Phase 2)UnknownNCT03845751
What this trial is testing

EvaluatioN of HIFU Hemiablation and Short Term AndrogeN Deprivation Therapy Combination to Enhance Prostate Cancer Control.

Who this might be right for
Prostate CancerAndrogen Deprivation Therapy
Institut Mutualiste Montsouris 20
Not applicableStudy completedNCT01423474
What this trial is testing

Prostate Accurately Targeted Radiotherapy Investigation of Overall Treatment Time

Who this might be right for
Prostatic Neoplasms
CancerCare Manitoba 152
Testing effectiveness (Phase 2)Looking for participantsNCT07332000
What this trial is testing

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Who this might be right for
Prostate Cancer Patients Treated by RadiotherapyProstate Cancer (Adenocarcinoma)
Candel Therapeutics, Inc. 45
Large-scale testing (Phase 3)Looking for participantsNCT01492972
What this trial is testing

Hypo-fractionated Radiation Therapy With or Without Androgen Suppression for Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
Proton Collaborative Group 192
Not applicableActive Not RecruitingNCT04909294
What this trial is testing

Evaluation of the Efficacy and the Safety of a Stereotaxic Prostatic Radiotherapy Delivered With Linac MRI, in Patients With Prostate Adenocarcinoma

Who this might be right for
Adenocarcinoma of the Prostate
Centre Georges Francois Leclerc 68
Very early researchNot Yet RecruitingNCT07727473
What this trial is testing

Preoperative Semaglutide Prior to Radical Prostatectomy

Who this might be right for
Prostate Cancer
Banner Health 20
Not applicableStudy completedNCT01657942
What this trial is testing

Focal MR-Guided Focused Ultrasound Treatment of Localized Intermediate Risk Prostate Lesions

Who this might be right for
Localized Intermediate Risk Prostate Lesions
InSightec 101
Testing effectiveness (Phase 2)UnknownNCT02077335
What this trial is testing

Study of High-dose Rate (HDR) Monotherapy for Low and Intermediate Risk Prostate Cancer

Who this might be right for
Prostate Cancer
CSSS de Gatineau 50
Early research (Phase 1)Study completedNCT02064036
What this trial is testing

Stereotactic Boost and Long-Term Androgen Deprivation for Adenocarcinoma of the Prostate

Who this might be right for
Adenocarcinoma of the Prostate
University of California, Davis 17
Large-scale testing (Phase 3)Study completedNCT00005044
What this trial is testing

Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 1,579
Not applicableLooking for participantsNCT07792993
What this trial is testing

Focal Micro-boost Strategy in Patients With Intermediate- to High-risk Prostate Cancer (IR-HR PCa) Undergoing Hypofractionated Radiotherapy

Who this might be right for
Localized Prostate Cancer
Regina Elena Cancer Institute 82
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation